Long-term antibiotics use carries the risk of resistance and side effects, representing a gap in the market for a different ...

Bronchiectasis is a chronic airway suppurative disease in which recurrent airway infections, inflammation and remodeling have ...

Panelists discuss how reducing bronchiectasis exacerbations requires ... Antibiotic selection should be guided by regular sputum cultures and patient history. Patient education about exacerbation ...

Multinational observational studies have demonstrated that ~20% of bronchiectasis patients had elevated BECs and sputum eosinophil count, who had a shorter time to the next exacerbation.

Researchers have discovered in a new study that treating airway inflammation with the experimental drug brensocatib lowers the rate of pulmonary exacerbations in patients with bronchiectasis.

The prospective study enrolled 30 paediatric CF patients who underwent imaging and spirometry both before and following the ...

The leading Bronchiectasis Companies such as AstraZeneca, Insmed Incorporated, SolAeroMed, Boehringer Ingelheim, CSL Behring, ...

Symptoms of bronchiectasis include chronic cough with sputum (mucous) production, shortness of breath and fatigue. Acute exacerbations of the debilitating condition experienced by patients are ...

aeruginosa-positive sputum samples at screening ... given the concerns about bacterial infection in patients with bronchiectasis and the use of an antineutrophil agent," Bell and Grimwood wrote.

Allergic bronchopulmonary aspergillosis is a pulmonary disease occurring in patients with asthma or cystic fibrosis, consequent to a dysregulated immune response to inhaled Aspergillus conidia.